UTHR

Healthcare

United Therapeutics Corporation

$538.00+5.18 (+0.97%)

Prev Close

$532.82

Open

$533.83

High

$543.37

Low

$533.83

Volume

334.3K

Market Cap

$21.50B

P/E

27.95

Div Yield

—

Over the past 12 months, insider activity at United Therapeutics Corporation (UTHR) has been exclusively selling, with 0 insider purchases totaling $0.00 and 29 insider sales totaling $137.63M. The most recent insider transaction was by ROTHBLATT MARTINE A (director, officer: Chairperson & CEO), who sold $9.82M worth of shares on Mar 11, 2026. United Therapeutics Corporation operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $21.50B.

Buys (12M)

$0.00

Sells (12M)

$137.63M

Net Activity

Net Seller

$137.63M

Active Insiders

last 12 mo

UTHR Price Chart

UTHR Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 11, 2026↗	ROTHBLATT MARTINE A	director, officer: Chairperson & CEO	Sell	18,200	$539.74	$9.82M	9,270
Mar 10, 2026↗	ROTHBLATT MARTINE A	director, officer: Chairperson & CEO	Sell	18,322	$497.18	$9.11M	9,430
Mar 9, 2026↗	Olian Judy D.	director	Sell	200	$510.00	$102.0K	4,645
Mar 9, 2026↗	ROTHBLATT MARTINE A	director, officer: Chairperson & CEO	Sell	9,500	$484.55	$4.60M	9,351
Mar 5, 2026↗	CAUSEY CHRISTOPHER	director	Sell	40	$490.17	$19.6K	4,190
Mar 5, 2026↗	KURZWEIL RAY	director	Sell	9,820	$489.02	$4.80M	12,670
Mar 5, 2026↗	MAHON PAUL A	officer: EVP & GENERAL COUNSEL	Sell	16,600	$483.15	$8.02M	44,776
Mar 5, 2026↗	ROTHBLATT MARTINE A	director, officer: Chairperson & CEO	Sell	57,000	$378.45	$21.57M	9,630
Mar 5, 2026↗	Thompson Tommy G	director	Sell	4,000	$489.42	$1.96M	8,480
Mar 3, 2026↗	ROTHBLATT MARTINE A	director, officer: Chairperson & CEO	Sell	9,021	$515.39	$4.65M	9,151
Mar 2, 2026↗	Olian Judy D.	director	Sell	200	$509.55	$101.9K	4,845
Feb 25, 2026↗	CAUSEY CHRISTOPHER	director	Sell	1,000	$520.00	$520.0K	4,190
Feb 24, 2026↗	BENKOWITZ MICHAEL	officer: PRESIDENT AND COO	Sell	10,130	$472.13	$4.78M	0
Feb 19, 2026↗	MAHON PAUL A	officer: EVP & GENERAL COUNSEL	Sell	16,600	$476.34	$7.91M	44,465
Feb 18, 2026↗	BENKOWITZ MICHAEL	officer: PRESIDENT AND COO	Sell	7,875	$480.75	$3.79M	0
Feb 17, 2026↗	BENKOWITZ MICHAEL	PRESIDENT AND COO	Sell	22,500	$480.76	$10.82M	0
Feb 17, 2026↗	MALCOLM JAN	Director	Sell	100	$474.68	$47.5K	220
Feb 10, 2026↗	BENKOWITZ MICHAEL	officer: PRESIDENT AND COO	Sell	7,875	$474.65	$3.74M	0
Feb 5, 2026↗	MAHON PAUL A	officer: EVP & GENERAL COUNSEL	Sell	8,300	$483.25	$4.01M	44,604
Feb 3, 2026↗	BENKOWITZ MICHAEL	officer: PRESIDENT AND COO	Sell	7,875	$470.95	$3.71M	0
Feb 3, 2026↗	MALCOLM JAN	director	Sell	50	$474.23	$23.7K	270
Jan 28, 2026↗	BENKOWITZ MICHAEL	officer: PRESIDENT AND COO	Sell	30,349	$466.53	$14.16M	14,509
Jan 20, 2026↗	MALCOLM JAN	director	Sell	50	$460.98	$23.0K	320
Jan 15, 2026↗	MAHON PAUL A	officer: EVP & GENERAL COUNSEL	Sell	8,300	$469.89	$3.90M	43,642
Jan 13, 2026↗	BENKOWITZ MICHAEL	officer: PRESIDENT AND COO	Sell	7,875	$479.51	$3.78M	0
Jan 7, 2026↗	BENKOWITZ MICHAEL	officer: PRESIDENT AND COO	Sell	21,803	$487.59	$10.63M	12,271
Jan 6, 2026↗	CAUSEY CHRISTOPHER	director	Sell	1,000	$510.00	$510.0K	4,190
Jan 6, 2026↗	MALCOLM JAN	director	Sell	50	$495.01	$24.8K	370
Jan 5, 2026↗	CAUSEY CHRISTOPHER	director	Sell	1,000	$500.02	$500.0K	4,190

UTHR Insider Buying Activity

The following table shows recent insider purchases of United Therapeutics Corporation (UTHR) stock reported via SEC Form 4 filings.

No insider buying activity found for UTHR in the last 12 months.

UTHR Insider Selling Activity

The following table shows recent insider sales of United Therapeutics Corporation (UTHR) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 11, 2026↗	ROTHBLATT MARTINE A	director, officer: Chairperson & CEO	Sell	18,200	$539.74	$9.82M	9,270
Mar 10, 2026↗	ROTHBLATT MARTINE A	director, officer: Chairperson & CEO	Sell	18,322	$497.18	$9.11M	9,430
Mar 9, 2026↗	Olian Judy D.	director	Sell	200	$510.00	$102.0K	4,645
Mar 9, 2026↗	ROTHBLATT MARTINE A	director, officer: Chairperson & CEO	Sell	9,500	$484.55	$4.60M	9,351
Mar 5, 2026↗	CAUSEY CHRISTOPHER	director	Sell	40	$490.17	$19.6K	4,190
Mar 5, 2026↗	KURZWEIL RAY	director	Sell	9,820	$489.02	$4.80M	12,670
Mar 5, 2026↗	MAHON PAUL A	officer: EVP & GENERAL COUNSEL	Sell	16,600	$483.15	$8.02M	44,776
Mar 5, 2026↗	ROTHBLATT MARTINE A	director, officer: Chairperson & CEO	Sell	57,000	$378.45	$21.57M	9,630
Mar 5, 2026↗	Thompson Tommy G	director	Sell	4,000	$489.42	$1.96M	8,480
Mar 3, 2026↗	ROTHBLATT MARTINE A	director, officer: Chairperson & CEO	Sell	9,021	$515.39	$4.65M	9,151
Mar 2, 2026↗	Olian Judy D.	director	Sell	200	$509.55	$101.9K	4,845
Feb 25, 2026↗	CAUSEY CHRISTOPHER	director	Sell	1,000	$520.00	$520.0K	4,190
Feb 24, 2026↗	BENKOWITZ MICHAEL	officer: PRESIDENT AND COO	Sell	10,130	$472.13	$4.78M	0
Feb 19, 2026↗	MAHON PAUL A	officer: EVP & GENERAL COUNSEL	Sell	16,600	$476.34	$7.91M	44,465
Feb 18, 2026↗	BENKOWITZ MICHAEL	officer: PRESIDENT AND COO	Sell	7,875	$480.75	$3.79M	0
Feb 17, 2026↗	BENKOWITZ MICHAEL	PRESIDENT AND COO	Sell	22,500	$480.76	$10.82M	0
Feb 17, 2026↗	MALCOLM JAN	Director	Sell	100	$474.68	$47.5K	220
Feb 10, 2026↗	BENKOWITZ MICHAEL	officer: PRESIDENT AND COO	Sell	7,875	$474.65	$3.74M	0
Feb 5, 2026↗	MAHON PAUL A	officer: EVP & GENERAL COUNSEL	Sell	8,300	$483.25	$4.01M	44,604
Feb 3, 2026↗	BENKOWITZ MICHAEL	officer: PRESIDENT AND COO	Sell	7,875	$470.95	$3.71M	0
Feb 3, 2026↗	MALCOLM JAN	director	Sell	50	$474.23	$23.7K	270
Jan 28, 2026↗	BENKOWITZ MICHAEL	officer: PRESIDENT AND COO	Sell	30,349	$466.53	$14.16M	14,509
Jan 20, 2026↗	MALCOLM JAN	director	Sell	50	$460.98	$23.0K	320
Jan 15, 2026↗	MAHON PAUL A	officer: EVP & GENERAL COUNSEL	Sell	8,300	$469.89	$3.90M	43,642
Jan 13, 2026↗	BENKOWITZ MICHAEL	officer: PRESIDENT AND COO	Sell	7,875	$479.51	$3.78M	0
Jan 7, 2026↗	BENKOWITZ MICHAEL	officer: PRESIDENT AND COO	Sell	21,803	$487.59	$10.63M	12,271
Jan 6, 2026↗	CAUSEY CHRISTOPHER	director	Sell	1,000	$510.00	$510.0K	4,190
Jan 6, 2026↗	MALCOLM JAN	director	Sell	50	$495.01	$24.8K	370
Jan 5, 2026↗	CAUSEY CHRISTOPHER	director	Sell	1,000	$500.02	$500.0K	4,190